362.1 Increases in donor-derived cell-free DNA prior to biopsy proven rejection in kidney transplant
Jonathan Bromberg, United States
362.2 dd-cfDNA levels are elevated in DSA-positive ABMR and DSA-negative ABMR kidney recipients undergoing indication biopsy for acute graft dysfunction
Monica Rika Nakamura, Brazil
362.3 Utilization of AlloView Integrative dd-cfDNA Model in Predicting the Risk of Kidney Allograft Rejection
Shree H Patel, United States
362.5 Impact of race on peripheral blood gene expression profile and renal function changes: An interim report of the TRULO study
James Fleming, United States
362.6 Anesthetic management of kidney transplantation patients with heart failure with reduced ejection fraction
Dr. Estherlyn M Magkachi, Philippines
362.7 Utilization of single-use flexible ureterorenoscope for ex-vivo stone extraction in living kidney donors
Dr. Emre Arpali, United States
362.8 Robotic assisted kidney transplantation: An analysis of early surgical experience